anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Fraud Exposure

Framework collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 6,793
Current window 4,951-4,980
Pages 227
Rows per page 30
Framework: Fraud Exposureclear collectionreset all
18 30 60

Framework

4,951-4,980 of 6,793

filter-aware
245
The slide uses red text and boxes to emphasize the contradiction between the trial paper's claims and the EMA's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
268
The slide uses highlighted text to emphasize the doctor's skepticism regarding the drug's 'game-changer' status and the saturation of his patient base.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a 'preempt_rebuttal' or 'expose_contradiction' style to challenge the scientific validity of a drug's mechanism of action claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a 'fraud-exposure' approach by highlighting circular citations and methodological weaknesses in the foundational research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
299
The slide uses scientific data to challenge the validity of the drug's efficacy claims by highlighting the high dosage required in animal models.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
300
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses a specific academic paper to undermine the scientific premise of a drug's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses box-whisker plots to demonstrate a lack of correlation between histamine/metabolite levels and various sleep disorder etiologies.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses a direct quote from a scientific editorial to discredit a previously held hypothesis regarding pitolisant's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
307
The slide uses a combination of narrative argument and direct excerpts from regulatory documents to highlight a discrepancy in drug efficacy claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
308
The slide uses a strong accusatory tone, alleging fraudulent claims and intent to mislead the FDA.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
309
The slide uses a combination of summary points and direct excerpts from a pharmacology consultant's review to build a case of scientific negligence or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
311
The slide uses expert testimony and raw data tables to challenge the validity of the reported pharmacokinetics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
314
The slide uses red boxes and text annotations to highlight specific data points in the charts that contradict expected clinical outcomes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
316
The slide uses a 'villain' narrative by comparing Harmony's practices to the Insys case and official government fraud alerts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
320
The slide uses highlighted text to emphasize key admissions regarding prescription volume and the criminal nature of the speaker program.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a 'fraud-exposure' narrative by contrasting the official label with market reality.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
331
The slide uses a Q&A format to highlight discrepancies in prescription volumes across similar-sized territories.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses direct quotes from two different ex-Harmony territory managers to build a case of systemic non-compliance and arbitrary quota setting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses a Q&A format to build a case for regulatory or ethical misconduct.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
349
The slide uses a Q&A transcript format to build a case of fraudulent business practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
353
The slide uses a Q&A format to highlight systemic issues and potential regulatory non-compliance regarding speaker programs and off-label prescriptions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
355
The slide uses a Q&A format to build a narrative of corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
10
The slide highlights a discrepancy between market cap rank (64th in Japan) and trading volume (top 10 globally), comparing it to tech giants and semiconductor peers.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
11
The slide uses a narrative of 'CEO resignation at peak' as a red flag for potential fraud, citing Enron and Scorpion Capital's analysis.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
14
The slide uses a narrative of 'the lie that grows' to characterize Lasertec, drawing parallels to Toshiba and Olympus.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
15
The slide uses a narrative of 'accounting fraud' to frame the financial data. The charts show a divergence between high EBIT margins and low/negative free cash flow relative to market cap.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
16
The slide uses a combination of narrative accusation and comparative data visualization to build a case for financial manipulation.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit